On the public citation graph

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

https://doi.org/10.1016/j.idc.2010.01.008

0 signed · 309 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archopht.1994.01090150102031openalex-snapshot

The Eye in Bone Marrow Transplantation

inferredcites →https://doi.org/10.1002/jmv.1890420216openalex-snapshot

Natural killer cell responses in renal transplant patients with cytomegalovirus infection

inferredcites →https://doi.org/10.1002/jmv.21397openalex-snapshot

Successful valganciclovir treatment of post‐transplant cytomegalovirus infection in the presence of UL97 mutation N597D

inferredcites →https://doi.org/10.1002/rmv.574openalex-snapshot

Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir

inferredcites →https://doi.org/10.1007/978-3-540-77349-8_4openalex-snapshot

Cytomegalovirus Cell Tropism

inferredcites →https://doi.org/10.1007/s12185-008-0249-2openalex-snapshot

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

inferredcites →https://doi.org/10.1016/j.antiviral.2006.05.002openalex-snapshot

Antiviral drugs for cytomegalovirus diseases

inferredcites →https://doi.org/10.1016/j.bbmt.2003.10.001openalex-snapshot

Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

inferredcites →https://doi.org/10.1016/j.bbmt.2004.11.016openalex-snapshot

Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation

inferredcites →https://doi.org/10.1016/j.bbmt.2005.12.038openalex-snapshot

Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host Disease of the Gastrointestinal Tract

inferredcites →https://doi.org/10.1016/j.bbmt.2006.12.454openalex-snapshot

Cytomegalovirus Infections following Umbilical Cord Blood Transplantation Using Reduced Intensity Conditioning Regimens for Adult Patients

inferredcites →https://doi.org/10.1016/j.bbmt.2007.06.006openalex-snapshot

Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources

inferredcites →https://doi.org/10.1016/j.bbmt.2008.09.001openalex-snapshot

The Effect of In Vivo T Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia

inferredcites →https://doi.org/10.1016/j.bbmt.2008.10.023openalex-snapshot

Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy

inferredcites →https://doi.org/10.1016/j.bbmt.2008.11.030openalex-snapshot

The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation

inferredcites →https://doi.org/10.1016/j.bbmt.2009.02.009openalex-snapshot

Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation

inferredcites →https://doi.org/10.1016/j.bcmd.2007.07.002openalex-snapshot

CMV-specific T cell therapy

inferredcites →https://doi.org/10.1016/j.jcv.2006.07.010openalex-snapshot

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet

inferredcites →https://doi.org/10.1016/s0140-6736(00)02350-3openalex-snapshot

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

inferredcites →https://doi.org/10.1016/s0140-6736(87)92800-5openalex-snapshot

IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS

inferredcites →https://doi.org/10.1016/s0140-6736(94)91835-xopenalex-snapshot

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation

inferredcites →https://doi.org/10.1023/a:1024580531705openalex-snapshot

Large Numbers of Dysfunctional CD8+ T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old

inferredcites →https://doi.org/10.1034/j.1399-3062.1999.010305.xopenalex-snapshot

Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy

inferredcites →https://doi.org/10.1034/j.1399-3062.2001.00004.xopenalex-snapshot

Cytomegalovirus drug resistance and clinical implications

inferredcites →https://doi.org/10.1034/j.1399-3062.2002.01018.xopenalex-snapshot

CMV retinitis after allogeneic bone marrow transplantation: a report of five cases

inferredcites →https://doi.org/10.1038/bmt.2008.120openalex-snapshot

CMV infections after hematopoietic stem cell transplantation

inferredcites →https://doi.org/10.1038/sj.bmt.1700801openalex-snapshot

Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

inferredcites →https://doi.org/10.1038/sj.bmt.1700967openalex-snapshot

Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient

inferredcites →https://doi.org/10.1038/sj.bmt.1701113openalex-snapshot

Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)

inferredcites →https://doi.org/10.1038/sj.bmt.1701139openalex-snapshot

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

inferredcites →https://doi.org/10.1038/sj.bmt.1701827openalex-snapshot

Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance

inferredcites →https://doi.org/10.1038/sj.bmt.1702226openalex-snapshot

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

inferredcites →https://doi.org/10.1038/sj.bmt.1702227openalex-snapshot

Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation

inferredcites →https://doi.org/10.1038/sj.bmt.1702526openalex-snapshot

CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy

inferredcites →https://doi.org/10.1038/sj.bmt.1702608openalex-snapshot

A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy

inferredcites →https://doi.org/10.1038/sj.bmt.1702877openalex-snapshot

Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

inferredcites →https://doi.org/10.1038/sj.bmt.1703764openalex-snapshot

Early infections in adult patients undergoing unrelated donor cord blood transplantation

inferredcites →https://doi.org/10.1038/sj.bmt.1704505openalex-snapshot

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT

inferredcites →https://doi.org/10.1038/sj.bmt.1704694openalex-snapshot

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

inferredcites →https://doi.org/10.1038/sj.bmt.1705341openalex-snapshot

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

inferredcites →https://doi.org/10.1038/sj.bmt.1705403openalex-snapshot

Adult umbilical cord blood transplantation: a comprehensive review

inferredcites →https://doi.org/10.1038/sj.bmt.1705468openalex-snapshot

Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders

inferredcites →https://doi.org/10.1038/sj.bmt.1705585openalex-snapshot

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1038/sj.bmt.1705699openalex-snapshot

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

inferredcites →https://doi.org/10.1038/sj.bmt.1705825openalex-snapshot

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT

inferredcites →https://doi.org/10.1038/sj.bmt.1705910openalex-snapshot

Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation

inferredcites →https://doi.org/10.1038/sj.leu.2400672openalex-snapshot

Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment

inferredcites →https://doi.org/10.1046/j.1365-2141.2000.02419.xopenalex-snapshot

Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

inferredcites →https://doi.org/10.1046/j.1365-2141.2001.02519.xopenalex-snapshot

Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft‐versus‐host disease prophylaxis

inferredcites →https://doi.org/10.1056/nejm198207013070102openalex-snapshot

Cytotoxic T Cells in Cytomegalovirus Infection

inferredcites →https://doi.org/10.1056/nejm198801143180202openalex-snapshot

Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation

inferredcites →https://doi.org/10.1056/nejm198906293202605openalex-snapshot

Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells

inferredcites →https://doi.org/10.1056/nejm199009133231103openalex-snapshot

Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation

inferredcites →https://doi.org/10.1056/nejm199104113241501openalex-snapshot

A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants

inferredcites →https://doi.org/10.1073/pnas.0605825103openalex-snapshot

Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes

inferredcites →https://doi.org/10.1073/pnas.140123497openalex-snapshot

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

inferredcites →https://doi.org/10.1073/pnas.91.25.11879openalex-snapshot

Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

inferredcites →https://doi.org/10.1080/00365540110080412openalex-snapshot

Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors

inferredcites →https://doi.org/10.1084/jem.188.6.1047openalex-snapshot

Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection

inferredcites →https://doi.org/10.1084/jem.20050882openalex-snapshot

Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects

inferredcites →https://doi.org/10.1086/314879openalex-snapshot

Cytomegalovirus (CMV)–Specific T Cell Immunity after Renal Transplantation Mediates Protection from CMV Disease by Limiting the Systemic Virus Load

inferredcites →https://doi.org/10.1086/318447openalex-snapshot

Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

inferredcites →https://doi.org/10.1086/338624openalex-snapshot

High Risk of Death Due to Bacterial and Fungal Infection among Cytomegalovirus (CMV)–Seronegative Recipients of Stem Cell Transplants from Seropositive Donors: Evidence for Indirect Effects of Primary CMV Infection

inferredcites →https://doi.org/10.1086/339329openalex-snapshot

Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients

inferredcites →https://doi.org/10.1086/339963openalex-snapshot

Comparative Analysis of CD8+T Cell Responses against Human Cytomegalovirus Proteins pp65 and Immediate Early 1 Shows Similarities in Precursor Frequency, Oligoclonality, and Phenotype

inferredcites →https://doi.org/10.1086/340637openalex-snapshot

Cytomegalovirus (CMV) Phosphoprotein 65 Makes a Large Contribution to Shaping the T Cell Repertoire in CMV‐Exposed Individuals

inferredcites →https://doi.org/10.1086/367836openalex-snapshot

Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

inferredcites →https://doi.org/10.1086/375743openalex-snapshot

Viral DNA Polymerase Mutations Associated with Drug Resistance in Human Cytomegalovirus

inferredcites →https://doi.org/10.1086/504811openalex-snapshot

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

inferredcites →https://doi.org/10.1086/514339openalex-snapshot

Relationship between Toll-Like Receptor 2 Polymorphism and Cytomegalovirus Disease after Liver Transplantation

inferredcites →https://doi.org/10.1086/515146openalex-snapshot

Late Cytomegalovirus Pneumonia in Adult Allogeneic Blood and Marrow Transplant Recipients

inferredcites →https://doi.org/10.1086/516484openalex-snapshot

Cytomegalovirus Monitoring by Polymerase Chain Reaction of Whole Blood Samples from Patients Undergoing Autologous Bone Marrow or Peripheral Blood Progenitor Cell Transplantation

inferredcites →https://doi.org/10.1086/588385openalex-snapshot

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

inferredcites →https://doi.org/10.1086/591185openalex-snapshot

Patterns of Cytomegalovirus Reactivation Are Associated with Distinct Evolutive Profiles of Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

inferredcites →https://doi.org/10.1086/591195openalex-snapshot

The Antiviral Activities of Artemisinin and Artesunate

inferredcites →https://doi.org/10.1086/598952openalex-snapshot

An Assessment of Donor‐to‐Recipient Transmission Patterns of Human Cytomegalovirus by Analysis of Viral Genomic Variants

inferredcites →https://doi.org/10.1086/599116openalex-snapshot

Diagnostic Performance of the Cytomegalovirus (CMV) Antigenemia Assay in Patients with CMV Gastrointestinal Disease

inferredcites →https://doi.org/10.1093/clinids/14.4.831openalex-snapshot

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

inferredcites →https://doi.org/10.1093/infdis/159.1.123openalex-snapshot

Identification of Multiple Strains of Cytomegalovirus in Homosexual Men

inferredcites →https://doi.org/10.1093/infdis/171.5.1115openalex-snapshot

Antiviral Antibody Responses and Intrauterine Transmission after Primary Maternal Cytomegalovirus Infection

inferredcites →https://doi.org/10.1093/infdis/172.4.939openalex-snapshot

Failure of High-Dose Acyclovir to Prevent Cytomegalovirus Disease after Autologous Marrow Transplantation

inferredcites →https://doi.org/10.1093/infdis/174.5.907openalex-snapshot

Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell Transplantation

inferredcites →https://doi.org/10.1093/jac/dkn521openalex-snapshot

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus

inferredcites →https://doi.org/10.1097/00007890-198812000-00022openalex-snapshot

GANCICLOVIR/IMMUNOGLOBULIN COMBINATION THERAPY FOR THE TREATMENT OF HUMAN CYTOMEGALOVIRUS-ASSOCIATED INTERSTITIAL PNEUMONIA IN BONE MARROW ALLOGRAFT RECIPIENTS

inferredcites →https://doi.org/10.1097/00007890-199306000-00024openalex-snapshot

CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATION

inferredcites →https://doi.org/10.1097/00007890-199811270-00012openalex-snapshot

RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1

inferredcites →https://doi.org/10.1097/00007890-200207150-00009openalex-snapshot

Risk factors for cytomegalovirus reactivation after CD6+ T-cell???depleted allogeneic bone marrow transplantation1

inferredcites →https://doi.org/10.1099/0022-1317-72-9-2059openalex-snapshot

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

inferredcites →https://doi.org/10.1111/j.1365-2141.1993.tb04641.xopenalex-snapshot

Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantation

inferredcites →https://doi.org/10.1111/j.1399-3046.2004.00175.xopenalex-snapshot

Risk factors in pediatric stem cell transplantation for leukemia

inferredcites →https://doi.org/10.1111/j.1399-3062.2006.00170.xopenalex-snapshot

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1111/j.1399-3062.2006.00183.xopenalex-snapshot

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1111/j.1399-3062.2007.00241.xopenalex-snapshot

Clinical features and outcomes of cytomegalovirus retinitis after transplantation

inferredcites →https://doi.org/10.1111/j.1399-3062.2007.00242.xopenalex-snapshot

Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease

inferredcites →https://doi.org/10.1111/j.1600-0609.2005.00625.xopenalex-snapshot

Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced‐intensity transplants

inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02513.xopenalex-snapshot

Interlaboratory Comparison of Cytomegalovirus Viral Load Assays

inferredcites →https://doi.org/10.1128/cmr.00034-08openalex-snapshot

Immunobiology of Human Cytomegalovirus: from Bench to Bedside

inferredcites →https://doi.org/10.1128/jcm.42.3.1142-1148.2004openalex-snapshot

Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR

inferredcites →https://doi.org/10.1128/jcm.44.5.1847-1850.2006openalex-snapshot

Polymorphisms in the Genes Encoding Chemokine Receptor 5, Interleukin-10, and Monocyte Chemoattractant Protein 1 Contribute to Cytomegalovirus Reactivation and Disease after Allogeneic Stem Cell Transplantation

inferredcites →https://doi.org/10.1128/jvi.64.11.5457-5464.1990openalex-snapshot

Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes

inferredcites →https://doi.org/10.1128/jvi.73.10.8179-8184.1999openalex-snapshot

Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited

inferredcites →https://doi.org/10.1128/jvi.74.17.8140-8150.2000openalex-snapshot

Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+T Lymphocytes in Healthy Seropositive Donors

inferredcites →https://doi.org/10.1128/jvi.77.8.4588-4596.2003openalex-snapshot

Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2

inferredcites →https://doi.org/10.1128/jvi.77.9.5226-5240.2003openalex-snapshot

Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers

inferredcites →https://doi.org/10.1128/jvi.79.24.15494-15502.2005openalex-snapshot

Human Cytomegalovirus UL97 Kinase Is Required for the Normal Intranuclear Distribution of pp65 and Virion Morphogenesis

inferredcites →https://doi.org/10.1128/jvi.79.5.2869-2879.2005openalex-snapshot

Identification of Cytomegalovirus-Specific Cytotoxic T Lymphocytes In Vitro Is Greatly Enhanced by the Use of Recombinant Virus Lacking the US2 to US11 Region or Modified Vaccinia Virus Ankara Expressing Individual Viral Genes

inferredcites →https://doi.org/10.1136/pgmj.64.751.389openalex-snapshot

Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation

inferredcites →https://doi.org/10.1182/blood-2002-03-0993openalex-snapshot

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

inferredcites →https://doi.org/10.1182/blood-2002-10-3143openalex-snapshot

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

inferredcites →https://doi.org/10.1182/blood-2002-10-3263openalex-snapshot

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

inferredcites →https://doi.org/10.1182/blood-2002-12-3636openalex-snapshot

Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial

inferredcites →https://doi.org/10.1182/blood-2002-12-3637openalex-snapshot

Stem cell transplantation for chronic myeloid leukemia in children

inferredcites →https://doi.org/10.1182/blood-2003-03-0824openalex-snapshot

Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles

inferredcites →https://doi.org/10.1182/blood-2003-10-3616openalex-snapshot

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

inferredcites →https://doi.org/10.1182/blood-2005-03-1039openalex-snapshot

Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation

inferredcites →https://doi.org/10.1182/blood-2005-09-3786openalex-snapshot

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1182/blood-2006-04-020313openalex-snapshot

Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening

inferredcites →https://doi.org/10.1182/blood-2007-01-069294openalex-snapshot

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

inferredcites →https://doi.org/10.1182/blood.v67.4.1162.1162openalex-snapshot

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease

inferredcites →https://doi.org/10.1182/blood.v75.9.1888.1888openalex-snapshot

Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment

inferredcites →https://doi.org/10.1182/blood.v78.5.1373.1373openalex-snapshot

Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease

inferredcites →https://doi.org/10.1182/blood.v80.5.1358.1358openalex-snapshot

Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation

inferredcites →https://doi.org/10.1182/blood.v81.7.1909.1909openalex-snapshot

Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells

inferredcites →https://doi.org/10.1182/blood.v83.7.1971.1971openalex-snapshot

Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis

inferredcites →https://doi.org/10.1182/blood.v86.7.2815.2815openalex-snapshot

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

inferredcites →https://doi.org/10.1182/blood.v86.9.3598.bloodjournal8693598openalex-snapshot

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]

inferredcites →https://doi.org/10.1182/blood.v88.10.4063.bloodjournal88104063openalex-snapshot

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

inferredcites →https://doi.org/10.1182/blood.v90.6.2502openalex-snapshot

Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and Outcome

inferredcites →https://doi.org/10.1182/blood.v93.1.394openalex-snapshot

Peripheral Blood CD14+ Cells From Healthy Subjects Carry a Circular Conformation of Latent Cytomegalovirus Genome

inferredcites →https://doi.org/10.1182/blood.v94.12.4029openalex-snapshot

Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation

inferredcites →https://doi.org/10.1182/blood.v95.7.2240openalex-snapshot

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

inferredcites →https://doi.org/10.1182/blood.v97.2.388openalex-snapshot

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

inferredcites →https://doi.org/10.1182/blood.v97.4.867openalex-snapshot

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

inferredcites →https://doi.org/10.1182/blood.v98.7.2043openalex-snapshot

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

inferredcites →https://doi.org/10.1182/blood.v99.10.3830openalex-snapshot

Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1182/blood.v99.4.1159openalex-snapshot

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

inferredcites →https://doi.org/10.1182/blood.v99.6.1978openalex-snapshot

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

inferredcites →https://doi.org/10.1182/blood.v99.8.3050openalex-snapshot

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

inferredcites →https://doi.org/10.1586/17434440.2.4.421openalex-snapshot

Ganciclovir implant in the treatment of cytomegalovirus retinitis

inferredcites →https://doi.org/10.3324/haematol.11912openalex-snapshot

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection

inferredcites →https://doi.org/10.4049/jimmunol.173.12.7481openalex-snapshot

Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection

inferredcites →https://doi.org/10.4049/jimmunol.177.10.7094openalex-snapshot

Human Cytomegalovirus Envelope Glycoproteins B and H Are Necessary for TLR2 Activation in Permissive Cells

inferredcites →https://doi.org/10.4049/jimmunol.178.7.4455openalex-snapshot

T Cell Recognition Patterns of Immunodominant Cytomegalovirus Antigens in Primary and Persistent Infection

inferredcites →https://doi.org/10.4049/jimmunol.180.7.4965openalex-snapshot

Differential Initiation of Innate Immune Responses Induced by Human Cytomegalovirus Entry into Fibroblast Cells

inferredcites →https://doi.org/10.7326/0003-4819-106-1-12openalex-snapshot

Intravenous Immune Globulin for Prevention of Cytomegalovirus Infection and Interstitial Pneumonia After Bone Marrow Transplantation

inferredcites →https://doi.org/10.7326/0003-4819-108-2-180openalex-snapshot

Rapid Detection of Cytomegalovirus Pulmonary Infection by Bronchoalveolar Lavage and Centrifugation Culture

inferredcites →https://doi.org/10.7326/0003-4819-109-10-777openalex-snapshot

Cytomegalovirus Pneumonia after Bone Marrow Transplantation Successfully Treated with the Combination of Ganciclovir and High-Dose Intravenous Immune Globulin

inferredcites →https://doi.org/10.7326/0003-4819-109-10-783openalex-snapshot

Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants

inferredcites →https://doi.org/10.7326/0003-4819-112-7-505openalex-snapshot

Ganciclovir for the Treatment of Cytomegalovirus Gastroenteritis in Bone Marrow Transplant Patients

inferredcites →https://doi.org/10.7326/0003-4819-118-3-199302010-00003openalex-snapshot

Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

inferredcites →https://doi.org/10.7326/0003-4819-118-3-199302010-00004openalex-snapshot

Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4005580openalex-extracted

The Establishment of a CMV-Specific CD8 + T-Cell Threshold by Kinetic Modelling for Prediction of Post-HSCT Reactivation

inferred← citeshttps://doi.org/10.1002/ajh.22214openalex-snapshot

The potential role of pre‐transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network

inferred← citeshttps://doi.org/10.1002/cld.500openalex-snapshot

Herpes virus infections

inferred← citeshttps://doi.org/10.1002/cpdd.1043openalex-snapshot

The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P‐Glycoprotein Substrate Digoxin in Healthy Volunteers

inferred← citeshttps://doi.org/10.1002/cpdd.1065openalex-snapshot

Pharmacokinetics, Safety, and Tolerability of NPC‐21, an Anti‐Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo‐Controlled, First‐in‐Human Phase 1 Study

inferred← citeshttps://doi.org/10.1002/cpdd.388openalex-snapshot

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

inferred← citeshttps://doi.org/10.1002/cpt.2456openalex-snapshot

Exposure–Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients

inferred← citeshttps://doi.org/10.1002/eji.201847526openalex-snapshot

Brain‐resident memory CD8+ T cells induced by congenital CMV infection prevent brain pathology and virus reactivation

inferred← citeshttps://doi.org/10.1002/hon.2453openalex-snapshot

Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant

inferred← citeshttps://doi.org/10.1002/jcph.1094openalex-snapshot

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects

inferred← citeshttps://doi.org/10.1002/jja2.12838openalex-snapshot

COVID–19に関連したサイトメガロウイルス再活性化による空腸潰瘍出血の1例(Jejunal ulcer hemorrhage due to COVID–19–related cytomegalovirus reactivation: a case report)

inferred← citeshttps://doi.org/10.1002/jmv.23412openalex-snapshot

Relationship between beta‐herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation

inferred← citeshttps://doi.org/10.1002/psp4.12593openalex-snapshot

Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients

inferred← citeshttps://doi.org/10.1007/978-3-030-50983-5_10openalex-snapshot

Viral Hepatitis Non: B, C, D and Acute and Acute on Chronic Liver Failure

inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_15openalex-snapshot

Cytomegalovirus Infections in Hematopoietic Cell Transplant and Solid Organ Transplant Recipients

inferred← citeshttps://doi.org/10.1007/978-3-319-28797-3_48openalex-snapshot

Adoptive Immunotherapy for Infection Control Using Antigen-Specific Donor-Derived T Cells After Transplantation

inferred← citeshttps://doi.org/10.1007/978-3-319-63146-2_21openalex-snapshot

Pulmonary Complications Associated with HSCT

inferred← citeshttps://doi.org/10.1007/bf03256431openalex-snapshot

Molecular Diagnosis and Management of Viral Infections in Hematopoietic Stem Cell Transplant Recipients

inferred← citeshttps://doi.org/10.1007/s00277-012-1632-xopenalex-snapshot

Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy

inferred← citeshttps://doi.org/10.1007/s00277-014-2222-xopenalex-snapshot

Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients

inferred← citeshttps://doi.org/10.1007/s00277-023-05474-1openalex-snapshot

Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection

inferred← citeshttps://doi.org/10.1007/s00277-023-05542-6openalex-snapshot

Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study

inferred← citeshttps://doi.org/10.1007/s00430-015-0388-zopenalex-snapshot

The history of vaccination against cytomegalovirus

inferred← citeshttps://doi.org/10.1007/s11239-011-0662-xopenalex-snapshot

Human cytomegalovirus infection and atherothrombosis

inferred← citeshttps://doi.org/10.1007/s12185-012-1087-9openalex-snapshot

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

inferred← citeshttps://doi.org/10.1007/s12185-021-03218-3openalex-snapshot

Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1016/b978-0-12-415948-8.00012-xopenalex-snapshot

Infections of the Kidney in Cancer Patients

inferred← citeshttps://doi.org/10.1016/b978-0-7020-6896-6.00037-5openalex-snapshot

Infections in the Immunocompromised Host

inferred← citeshttps://doi.org/10.1016/b978-0-7234-3691-1.00049-0openalex-snapshot

Infections in the immunocompromised host

inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00001-xopenalex-snapshot

Passive immunization

inferred← citeshttps://doi.org/10.1016/j.antiviral.2025.106259openalex-snapshot

First evidence of efficacy of peptides targeting the pUL56-pUL89 interaction domain of the human cytomegalovirus terminase complex

inferred← citeshttps://doi.org/10.1016/j.bbmt.2011.05.015openalex-snapshot

CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus

inferred← citeshttps://doi.org/10.1016/j.bbmt.2014.08.010openalex-snapshot

Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review

inferred← citeshttps://doi.org/10.1016/j.bbmt.2014.11.676openalex-snapshot

Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation

inferred← citeshttps://doi.org/10.1016/j.bbmt.2015.07.019openalex-snapshot

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related…

inferred← citeshttps://doi.org/10.1016/j.bbmt.2016.09.024openalex-snapshot

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning

inferred← citeshttps://doi.org/10.1016/j.bbmt.2017.06.022openalex-snapshot

Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia

inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.09.038openalex-snapshot

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.10.001openalex-snapshot

Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell…

inferred← citeshttps://doi.org/10.1016/j.cden.2013.12.001openalex-snapshot

Update on Oral Herpes Virus Infections

inferred← citeshttps://doi.org/10.1016/j.ejcb.2022.151239openalex-snapshot

The impact of RNA modifications on the biology of DNA virus infection

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2023.106860openalex-snapshot

Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants

inferred← citeshttps://doi.org/10.1016/j.ijid.2016.03.025openalex-snapshot

Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation

inferred← citeshttps://doi.org/10.1016/j.isci.2022.105340openalex-snapshot

The establishment of a cytomegalovirus -specific CD8+ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation

inferred← citeshttps://doi.org/10.1016/j.jaad.2014.03.020openalex-snapshot

Opportunistic infections in patients with pemphigus

inferred← citeshttps://doi.org/10.1016/j.jcv.2012.01.006openalex-snapshot

Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients

inferred← citeshttps://doi.org/10.1016/j.jcvp.2026.100259openalex-snapshot

Streamlining viral surveillance in transplant patients with the Alinity m Platform

inferred← citeshttps://doi.org/10.1016/j.jcyt.2026.102909openalex-snapshot

Impact of CMV infection on pediatric allogeneic HSCT outcomes in a region of high CMV seroprevalence: a non-TBI cohort study

inferred← citeshttps://doi.org/10.1016/j.jtct.2024.12.010openalex-snapshot

Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients

inferred← citeshttps://doi.org/10.1016/j.pcl.2020.09.003openalex-snapshot

Pulmonary Manifestations of Hematologic and Oncologic Diseases in Children

inferred← citeshttps://doi.org/10.1016/j.transproceed.2017.05.007openalex-snapshot

Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?

inferred← citeshttps://doi.org/10.1016/j.trim.2022.101539openalex-snapshot

Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells

inferred← citeshttps://doi.org/10.1016/s1473-3099(11)70344-9openalex-snapshot

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

inferred← citeshttps://doi.org/10.1038/bmt.2011.110openalex-snapshot

The EBMT risk score

inferred← citeshttps://doi.org/10.1038/bmt.2013.73openalex-snapshot

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

inferred← citeshttps://doi.org/10.1038/ncomms14321openalex-snapshot

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein

inferred← citeshttps://doi.org/10.1038/s41409-017-0016-1openalex-snapshot

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

inferred← citeshttps://doi.org/10.1038/s41409-018-0166-9openalex-snapshot

Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study

inferred← citeshttps://doi.org/10.1038/s41409-018-0172-yopenalex-snapshot

Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1038/s41409-022-01880-7openalex-snapshot

Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection

inferred← citeshttps://doi.org/10.1055/s-0046-1816045openalex-snapshot

Infectious Disease Marker Profile of Potential Matched Unrelated Donors for Hematopoietic Stem Cell Transplantation in North India

inferred← citeshttps://doi.org/10.1056/nejmoa1309533openalex-snapshot

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

inferred← citeshttps://doi.org/10.1073/pnas.1909143116openalex-snapshot

Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing

inferred← citeshttps://doi.org/10.1080/03007995.2019.1664827openalex-snapshot

Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant

inferred← citeshttps://doi.org/10.1080/17425255.2018.1550485openalex-snapshot

Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1080/1750743x.2026.2644106openalex-snapshot

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1080/23744235.2019.1650198openalex-snapshot

Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1084/jem.20160758openalex-snapshot

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection

inferred← citeshttps://doi.org/10.1089/vim.2023.0053openalex-snapshot

Differential Reactivation of Cytomegalovirus and Epstein–Barr Virus in Patients with B Cell Lymphoma

inferred← citeshttps://doi.org/10.1093/ajcp/aqw179openalex-snapshot

Immunohistochemistry Improves the Detection of Adenovirus in Gastrointestinal Biopsy Specimens From Hematopoietic Stem Cell Transplant Recipients

inferred← citeshttps://doi.org/10.1093/bmb/ldz031openalex-snapshot

Advances in the treatment of cytomegalovirus

inferred← citeshttps://doi.org/10.1093/cid/ciq055openalex-snapshot

Adoptive Therapy of Cytomegalovirus-Specific T Lymphocytes: Is Less More?

inferred← citeshttps://doi.org/10.1093/infdis/jiw073openalex-snapshot

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis

inferred← citeshttps://doi.org/10.1093/jac/dks043openalex-snapshot

Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study

inferred← citeshttps://doi.org/10.1093/mmy/myy138openalex-snapshot

A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection

inferred← citeshttps://doi.org/10.1093/ofid/ofv212openalex-snapshot

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis

inferred← citeshttps://doi.org/10.1093/ofid/ofx143openalex-snapshot

Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease

inferred← citeshttps://doi.org/10.1097/01.jaa.0000524712.40590.76openalex-snapshot

An introduction to gastrointestinal tract CMV disease

inferred← citeshttps://doi.org/10.1097/inf.0000000000000824openalex-snapshot

Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation

inferred← citeshttps://doi.org/10.1097/mph.0000000000002272openalex-snapshot

Is Monitoring of Cytomegalovirus Disease Required in Nontransplant Pediatric Acute Lymphoblastic Leukemia?

inferred← citeshttps://doi.org/10.1097/qco.0000000000001140openalex-snapshot

Approach to diarrhea in hematopoietic stem cell transplant recipients

inferred← citeshttps://doi.org/10.1097/tp.0000000000000272openalex-snapshot

Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells

inferred← citeshttps://doi.org/10.1097/tp.0000000000000986openalex-snapshot

Simultaneous Quantification of the 8 Human Herpesviruses in Allogeneic Hematopoietic Stem Cell Transplantation

inferred← citeshttps://doi.org/10.1097/tp.0b013e318242165dopenalex-snapshot

Preventative Tools of the Future

inferred← citeshttps://doi.org/10.1101/gad.319475.118openalex-snapshot

RNA m 6 A modification enzymes shape innate responses to DNA by regulating interferon β

inferred← citeshttps://doi.org/10.1111/bcp.13292openalex-snapshot

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

inferred← citeshttps://doi.org/10.1111/bcp.13376openalex-snapshot

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

inferred← citeshttps://doi.org/10.1111/ceo.13500openalex-snapshot

Viral retinitis: diagnosis and management in the era of biologic immunosuppression: A review

inferred← citeshttps://doi.org/10.1111/ctr.14024openalex-snapshot

Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients

inferred← citeshttps://doi.org/10.1111/cts.12483openalex-snapshot

Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial

inferred← citeshttps://doi.org/10.1111/j.1399-3062.2006.00183.xopenalex-snapshot

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation

inferred← citeshttps://doi.org/10.1111/j.1399-3062.2006.00199.xopenalex-snapshot

Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON®‐CMV

inferred← citeshttps://doi.org/10.1111/j.1399-3062.2007.00235.xopenalex-snapshot

Predictors for persistent cytomegalovirus reactivation after T‐cell‐depleted allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1111/j.1399-3062.2008.00325.xopenalex-snapshot

Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real‐world review

inferred← citeshttps://doi.org/10.1111/j.1600-0609.2012.01824.xopenalex-snapshot

Treatment with mesenchymal stromal cells is a risk factor for pneumonia‐related death after allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1111/petr.70033openalex-snapshot

CMV Reactivation Following Allogeneic Transplantation in Children From a High‐Seroprevalence Population: A Single‐Center Experience in Colombia

inferred← citeshttps://doi.org/10.1111/tid.12398openalex-snapshot

Risk factors and prognostic scale for cytomegalovirus ( CMV ) infection in CMV ‐seropositive patients after allogeneic hematopoietic cell transplantation

inferred← citeshttps://doi.org/10.1111/tid.12539openalex-snapshot

Half‐dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1128/aac.00854-13openalex-snapshot

A Peptide Inhibitor of Cytomegalovirus Infection from Human Hemofiltrate

inferred← citeshttps://doi.org/10.1128/aac.02467-19openalex-snapshot

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation

inferred← citeshttps://doi.org/10.1128/cmr.00198-24openalex-snapshot

Adoptive T-cell therapy for virus-associated diseases

inferred← citeshttps://doi.org/10.1128/jcm.00721-11openalex-snapshot

Cytomegalovirus DNA Quantification Using an Automated Platform for Nucleic Acid Extraction and Real-Time PCR Assay Setup

inferred← citeshttps://doi.org/10.1128/jvi.01850-14openalex-snapshot

Cognate CD4 T-Cell Licensing of Dendritic Cells Heralds Anti-Cytomegalovirus CD8 T-Cell Immunity after Human Allogeneic Umbilical Cord Blood Transplantation

inferred← citeshttps://doi.org/10.1128/jvi.01955-12openalex-snapshot

The Human Cytomegalovirus UL51 Protein Is Essential for Viral Genome Cleavage-Packaging and Interacts with the Terminase Subunits pUL56 and pUL89

inferred← citeshttps://doi.org/10.1128/jvi.02483-16openalex-snapshot

Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing

inferred← citeshttps://doi.org/10.1128/jvi.05265-11openalex-snapshot

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

inferred← citeshttps://doi.org/10.1128/mbio.00013-18openalex-snapshot

Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing

inferred← citeshttps://doi.org/10.1155/2016/5143071openalex-snapshot

Prognostic Factors on the Graft‐versus‐Host Disease‐Free and Relapse‐Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation

inferred← citeshttps://doi.org/10.11606/t.17.2021.tde-23062022-094634openalex-snapshot

Avaliação de marcadores séricos relacionados à ativação e à disfunção endotelial nos períodos pré e pós-transplante de células progenitoras hematopoéticas para tratamento da doença falciforme

inferred← citeshttps://doi.org/10.11641/pde.106.1_98openalex-snapshot

A case of first-episode ulcerative colitis detected by first infection with cytomegalovirus

inferred← citeshttps://doi.org/10.1172/jci45449openalex-snapshot

Cytomegalovirus: pathogen, paradigm, and puzzle

inferred← citeshttps://doi.org/10.1177/0885066613476454openalex-snapshot

Cytomegalovirus Pneumonia in Hematopoietic Stem Cell Recipients

inferred← citeshttps://doi.org/10.1182/blood-2015-03-631853openalex-snapshot

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

inferred← citeshttps://doi.org/10.1182/blood.2019003687openalex-snapshot

How I manage infection risk and prevention in patients with lymphoid cancer

inferred← citeshttps://doi.org/10.1182/blood.2021011459openalex-snapshot

Letermovir and HCT: too much of a good thing?

inferred← citeshttps://doi.org/10.1186/1756-8722-6-94openalex-snapshot

Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1186/s12879-018-3488-8openalex-snapshot

Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure

inferred← citeshttps://doi.org/10.1371/journal.pone.0160493openalex-snapshot

Comparison of Two Commercial Automated Nucleic Acid Extraction and Integrated Quantitation Real-Time PCR Platforms for the Detection of Cytomegalovirus in Plasma

inferred← citeshttps://doi.org/10.1371/journal.ppat.1006015openalex-snapshot

Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand

inferred← citeshttps://doi.org/10.1515/prolas-2016-0026openalex-snapshot

Effect of HHV-6 and HHV-7 Infection on the Posttransplant Process and the Development of Complications in Patients after Autologous Stem Cell Transplantation / HHV-6 Un HHV-7 Infekcijas Ietekme Uz Pēctransplantācijas Klīnisko Gaitu Un Komplikāciju Attīstību Pacientiem Pēc Autologas Cilmes Šūnu…

inferred← citeshttps://doi.org/10.1517/14728222.2013.740460openalex-snapshot

Coordination of late gene transcription of human cytomegalovirus with viral DNA synthesis: recombinant viruses as potential therapeutic vaccine candidates

inferred← citeshttps://doi.org/10.1517/21678707.2013.842166openalex-snapshot

Prevention of cytomegalovirus disease in patients with impaired cell-mediated immunity – is there a need for maribavir?

inferred← citeshttps://doi.org/10.1556/2068.2019.52.1.13openalex-snapshot

CMV-infekció autológ őssejt-transzplantált betegekben. Surveillance-vizsgálat vagy tünetek vezérelte diagnosztika szükséges?

inferred← citeshttps://doi.org/10.17827/aktd.41320openalex-snapshot

Allojenik Hematopoetik Kök Hücre Transplant Alıcılarında Viral İnfeksiyonların Yönetimi

inferred← citeshttps://doi.org/10.18388/abp.2015_1162openalex-snapshot

Multiplex real-time PCR to identify a possible reinfection with different strains of human cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

inferred← citeshttps://doi.org/10.18621/eurj.573407openalex-snapshot

Investigation of the effect of chemotherapy on cytomegalovirus reactivity in patients with solid organ tumors

inferred← citeshttps://doi.org/10.18632/oncotarget.14504openalex-snapshot

Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies

inferred← citeshttps://doi.org/10.18821/0507-4088-2018-63-5-202-211openalex-snapshot

MODERN ETHIOTROPIC CHEMOTHERAPY OF HUMAN CYTOMEGALOVIRUS INFECTION: CLINICAL EFFECTIVENESS, MOLECULAR MECHANISM OF ACTION, DRUG RESISTANCE, NEW TRENDS AND PROSPECTS. PART 1

inferred← citeshttps://doi.org/10.2147/ijctm.s115669openalex-snapshot

Current strategies and future directions for the prevention of transfusion-transmitted cytomegalovirus

inferred← citeshttps://doi.org/10.21859/isv.9.4.9openalex-snapshot

Cytomegalovirus PCR Analysis of Serum and Ocular Swab Samples in Patients with Inflammatory Eye Disease

inferred← citeshttps://doi.org/10.2217/fvl.11.30openalex-snapshot

Recent Developments in Antiviral Drugs for CytomegAlovirus

inferred← citeshttps://doi.org/10.2217/fvl.12.8openalex-snapshot

The Immune Response to Human CMV

inferred← citeshttps://doi.org/10.3233/pic-14094openalex-snapshot

A review of graft versus host disease

inferred← citeshttps://doi.org/10.3324/haematol.2015.123687openalex-snapshot

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

inferred← citeshttps://doi.org/10.3324/haematol.2023.284544openalex-snapshot

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

inferred← citeshttps://doi.org/10.3346/jkms.2026.41.e86openalex-snapshot

Harnessing Cytomegalovirus DNAemia and CMV-Specific Cell-Mediated Immunity in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

inferred← citeshttps://doi.org/10.3389/fimmu.2013.00036openalex-snapshot

Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor

inferred← citeshttps://doi.org/10.3389/fimmu.2013.00276openalex-snapshot

Monitoring of Pathogen-Specific T-Cell Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

inferred← citeshttps://doi.org/10.3389/fimmu.2024.1338499openalex-snapshot

Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

inferred← citeshttps://doi.org/10.3390/cancers11121842openalex-snapshot

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity

inferred← citeshttps://doi.org/10.3390/ijms21103663openalex-snapshot

Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation

inferred← citeshttps://doi.org/10.3390/jcm11175187openalex-snapshot

The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder

inferred← citeshttps://doi.org/10.3390/microorganisms9051059openalex-snapshot

Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens—A Novel, Automated Immunohistochemical Staining Protocol

inferred← citeshttps://doi.org/10.3390/v15030732openalex-snapshot

Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study

inferred← citeshttps://doi.org/10.3390/v6010354openalex-snapshot

Analysis of Essential Viral Gene Functions after Highly Efficient Adenofection of Cells with Cloned Human Cytomegalovirus Genomes

inferred← citeshttps://doi.org/10.3390/v7031391openalex-snapshot

Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes

inferred← citeshttps://doi.org/10.4049/jimmunol.1201759openalex-snapshot

Reconstitution of Protective Immune Responses against Cytomegalovirus and Varicella Zoster Virus Does Not Require Disease Development in Pediatric Recipients of Umbilical Cord Blood Transplantation

inferred← citeshttps://doi.org/10.4067/s0716-10182014000200005openalex-snapshot

Detección precoz de infección por citomegalovirus en pacientes sometidos a trasplante alogéneico de precursores hematopoyéticos por reacción de polimerasa en cadena cuantitativa en tiempo real

inferred← citeshttps://doi.org/10.4084/mjhid.2020.025openalex-snapshot

CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

inferred← citeshttps://doi.org/10.4103/2279-042x.176554openalex-snapshot

The risk factors for cytomegalovirus reactivation following stem cell transplantation

inferred← citeshttps://doi.org/10.4103/ojo.ojo_28_22openalex-snapshot

Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.5114/ceji.2013.37749openalex-snapshot

Case report Combined umbilical cord blood and bone marrow transplantation from a sibling in a patient with Fanconi anemia

inferred← citeshttps://doi.org/10.5114/ceji.2014.45953openalex-snapshot

Clinical immunology Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency

inferred← citeshttps://doi.org/10.5144/1658-3876.2011.67openalex-snapshot

Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients

inferred← citeshttps://doi.org/10.5500/wjt.v5.i3.129openalex-snapshot

Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study

inferred← citeshttps://doi.org/10.5578/llm.20229802openalex-snapshot

Otolog Kök Hücre Transplantasyonunda Sitomegalovirüs (CMV) ve Hepatit B (HBV) Reaktivasyonu: Tek Merkez Deneyimi

inferred← citeshttps://doi.org/10.7554/elife.49551openalex-snapshot

Ribosome biogenesis restricts innate immune responses to virus infection and DNA

inferred← citeshttps://doi.org/10.7860/jcdr/2017/28148.10302openalex-snapshot

Detection of Cytomegalovirus in Bronchoalveolar Lavage Fluid from HIV-Positive Individuals with Community Acquired Pneumonia

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.